Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Valiant Laboratories Ltd.

NSE: VALIANTLAB | BSE:543998

₹139.20 -0.93 (-0.66%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

138.50

Today’s High

141.20

52W low

129.30

52W High

215.00

Open Price

140.40

Prev. Close

140.0500

Volume

156412.00

Value

21772550.40

Fundamentals

Market Cap Cr

604.80

Price to Earnings

1892.30

Price to Book Value

2.60

Dividend Yield

0.00

PE to Growth

-19.10

Op Revenue TTM Cr

182.06

Net Profit TTM Cr

0.32

Cash From Operating Activity Cr

1.89

Return on Equity %

0.13

EMA & SMA

Bullish Moving Averages

0

Bearish Moving Averages

14

5Day EMA

140

10Day EMA

141.2

12Day EMA

141.6

20Day EMA

142.6

26Day EMA

143.4

50Day EMA

146.9

100Day EMA

154.3

EMA

5Day SMA

139.9

10Day SMA

141.3

20Day SMA

143.5

30Day SMA

143.2

50Day SMA

146.5

100Day SMA

155.3

150Day SMA

164.2

SMA

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

03 Jul, 2024

48.3

Week

28.4

Month

34.3

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

139.62

PIVOT

First Resistance

140.74

Second Resistance

142.28

Third Resistance

143.40

First Support

138.08

Second Support

136.96

Third Support

135.42

Relative Strength Index

41.97

Money Flow Index

40.58

MACD

-1.84

MACD Signal

-1.48

Average True Range

5.52

Average Directional Index

18.2

Rate of Change (21)

-3.23

Rate of Change (125)

-20.55

Commodity Channel Index

-76.2

Williams %R

-82.9

BETA

1 Month

1.01

3 Month

1.13

1 Year

3 Year

PRICE CHANGE ANALYSIS

↓ -2.61%

1 Week

Low

High

136.5

144.94

↑ 1.94%

1 Month

Low

High

129.3

153.9

↓ -9.67%

3 Months

Low

High

129.3

171.9

↓ -19.65%

6 Months

Low

High

129.3

214.95

↓ -0.57%

1 Year

Low

High

129.3

214.95

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Graph
Total Qtr Revenue cr 33.09 42.29 62.51 53.85 91.64 71.56
Operating Expenses Qtr 35.11 46.82 60.93 47.59 81.31 60.85
Operating Profit Qtr -4.53 -6.31 -1.39 3.81 8.61 9.93
EBIDT Qtr Cr -2.03 -4.53 1.57 6.26 10.34 10.71
Depreciation Qtr 0.50 0.49 0.49 0.46 0.44 0.40
Net Profit Qtr -1.22 -3.50 0.79 4.27 7.83 7.65
Basic EPS Qtr -0.32 -0.81 0.24 1.31 2.41 4.70
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Total Revenue Annual 191.73 338.77 293.47 183.78
Operating Expenses Annual Cr 190.46 298.82 249.21 132.37
Operating Profit Annual -8.41 35.09 42.32 50.00
Operating Profit Margin Annual % -4.39 10.36 14.42 27.21
Total Expenses Annual Cr 192.49 300.64 251.77 136.76
EBIDT Annual Cr 1.27 39.95 44.27 51.41
EBIDT Annual margin % 0.66 11.79 15.08 27.98
Depreciation 1.95 1.56 2.49 2.61
PAT Before ExtraOrdinary Items Annual Cr 0.34 29.00 27.50 30.59
Net Profit Annual 0.34 29.00 27.50 30.59
Basic EPS Annual 0.14 8.91 9.52 10.83
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Total ShareHolders Funds Annual 236.88 100.49 71.46 88.58
Minority Interest Liability Annual Cr - - - -
Total Non Current Liabilities Annual Cr 61.48 61.75 60.92 1.84
Total Current Liabilities Annual Cr 26.36 50.52 49.43 15.89
Total Capital Plus Liabilities Annual Cr 324.73 212.76 181.81 106.31
Fixed Assets Annual 31.83 30.02 23.67 19.79
Total Non Current Assets Annual 115.46 30.80 25.02 20.42
Total Current Assets Annual 209.27 181.96 156.80 85.89
Total Assets Annual 324.73 212.76 181.81 106.31
Contingent Liabilities plus Commitments Annual Cr - 0.42 0.87 0.00
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Cash from Operating Activity Annual 48.78 22.96 2.25 9.11
Cash from Investing Activity Annual -182.73 -21.18 -12.24 -16.67
Cash from Financing Annual Activity 135.80 -1.53 6.18 11.43
Net Cash Flow Annual - 0.24 -3.81 3.87
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Book Value Per Share Annual 54.52 30.86 43.89 84.36
ROE Annual % 0.14 28.85 38.47 34.53
ROCE Annual % -0.22 23.66 31.55 53.97
Total Debt to Total Equity Annual 0.25 0.59 0.85 0.00
EBDIT Annual Margin % 0.69 11.96 15.18 28.19
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Graph
Total Qtr Revenue cr 33.09 42.29 62.51 53.85 94.01 71.56
Operating Expenses Qtr 35.12 46.82 60.93 47.59 81.34 60.85
Operating Profit Qtr -4.53 -6.31 -1.39 3.81 9.93 9.93
EBIDT Qtr Cr -2.03 -4.53 1.57 6.26 12.67 10.71
Depreciation Qtr 0.52 0.49 0.49 0.46 0.44 0.40
Net Profit Qtr -1.24 -3.50 0.79 4.27 10.00 7.65
Basic EPS Qtr -0.33 -0.81 0.24 1.31 2.41 4.70
Indicator Mar 2024 Mar 2023 Graph
Total Revenue Annual 191.74 338.77
Operating Expenses Annual Cr 190.46 298.82
Operating Profit Annual -8.41 35.09
Operating Profit Margin Annual % -4.38 10.36
Total Expenses Annual Cr 192.51 300.64
EBIDT Annual Cr 1.27 39.95
EBIDT Annual margin % 0.66 11.79
Depreciation 1.97 1.56
PAT Before ExtraOrdinary Items Annual Cr 0.32 29.00
Net Profit Annual 0.32 29.00
Basic EPS Annual 0.13 8.91
Indicator Mar 2024 Mar 2023 Graph
Total ShareHolders Funds Annual 236.86 100.49
Minority Interest Liability Annual Cr 0.00 0.00
Total Non Current Liabilities Annual Cr 76.75 61.75
Total Current Liabilities Annual Cr 29.08 50.73
Total Capital Plus Liabilities Annual Cr 342.69 212.97
Fixed Assets Annual 92.70 48.80
Total Non Current Assets Annual 117.14 62.39
Total Current Assets Annual 225.54 150.58
Total Assets Annual 342.69 212.97
Contingent Liabilities plus Commitments Annual Cr - 0.42
Indicator Mar 2024 Mar 2023 Graph
Cash from Operating Activity Annual 1.89 56.05
Cash from Investing Activity Annual -143.88 -55.17
Cash from Financing Annual Activity 152.45 -0.93
Net Cash Flow Annual - -0.05
Indicator Mar 2024 Mar 2023 Graph
Book Value Per Share Annual 54.51 30.86
ROE Annual % 0.13 28.85
ROCE Annual % -0.22 23.66
Total Debt to Total Equity Annual 0.32 0.59
EBDIT Annual Margin % 0.69 11.96
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
Paresh Shashikant Shah 9.36 74504518 0 100
Santosh Shantilal Vora 7.5 74504519 0 100
Shantilal Shivji Vora 7.5 74504520 0 100
Kanchan Shantilal Vora 3.72 74504521 0 100
Dhanvallabh Ventures LLP 46.84 74504525 0 100
Name Holding Percent Holding Id
Vikasa India Eif I Fund - Incube Global Opportunities 1.89 74504529
Saint Capital Fund 1.18 74504530
Name Holding Percent Holding Id
Niraj Rajnikant Shah 1.39 74504536
Jainam Broking Limited 1.93 74504533
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
May 14, 2024 Audited Results -
Feb 09, 2024 Quarterly Results -
Nov 06, 2023 Quarterly Results -
Ex-Date Bonus Ratio Record Date
Bigul
26 Jun 2024

Valiant Laboratories Ltd - 543998 - Closure of Trading Window

 Intimation of closure of trading window
Bigul
21 Jun 2024

Valiant Laboratories Ltd - 543998 - Intimation Under Regulation 30 Of SEBI (LODR), 2015.

 Intimation under Regulation 30 of SEBI (LODR), 2015.
Bigul
27 May 2024

Valiant Laboratories Ltd - 543998 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant To Regulation 24(A) of SEBI (LODR), 2015, enclosed is the copy of Annual Secretarial Compliance Report for the year ended March 31, 2024
Bigul
16 May 2024

Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper Publication of Standalone and Consolidated Audited Financial Results for the quarter and year ended March 31, 2024.
Bigul
14 May 2024

Valiant Laboratories Ltd - 543998 - Statement Of Deviation & Variation For Quarter Ended March 31, 2024.

 Statement of Deviation & Variation for quarter ended March 31, 2024
Bigul
14 May 2024

Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

 Monitoring Agency Report for quarter ended March 31, 2024
Bigul
14 May 2024

Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Change in Directorate

 Appointment of Mr. Mulesh Manilal Savla as Non- Executive Independent Director of the Company.
Bigul
14 May 2024

Valiant Laboratories Ltd - 543998 - Re-Appointment Of Cost Auditor, Internal Auditor And Secretarial Auditor

 Re-appointment of Cost Auditor, Internal Auditor and Secretarial Auditor of the Company for FY 2024-2025.
Bigul
14 May 2024

Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

 Re-appointment of M/s Raman Shah & Co. as Statutory Auditors of the Company.
Bigul
14 May 2024

Valiant Laboratories Ltd - 543998 - Appointment of Company Secretary and Compliance Officer

 Appointment of Ms. Prajakta Patil as the Company Secretary & Compliance Officer of the Company.
See all News

FAQs

The latest market price of Valiant Laboratories Ltd. on NSE was Rs. 139.20 as of today.

The opening share price of Valiant Laboratories Ltd. was Rs. 140.40 as of today.

The 52-week high share price of Valiant Laboratories Ltd. was Rs. 215.00.

The 52 week low share price of Valiant Laboratories Ltd. was Rs. 129.30.

Valiant Laboratories Ltd. has a market cap of Rs. 604.80 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Valiant Laboratories Ltd. is -19.10. Please refer to the Fundamentals section for further details.

The operating revenue for Valiant Laboratories Ltd. in the last FY was Rs.  182.06 crore. Please refer to the Financials section for further details.

The Net Profit for Valiant Laboratories Ltd. in the last FY was Rs. 0.32 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Valiant Laboratories Ltd..

Close

Let's Open Free Demat Account